Literature DB >> 24966095

Prevalence of epilepsy--an unknown quantity.

Ettore Beghi1, Dale Hesdorffer.   

Abstract

The incidence, prevalence, and mortality of epilepsy vary across countries with different economies. Differences can be explained by methodological problems, premature mortality, seizure remission, socioeconomic factors, and stigma. Diagnostic misclassification-one possible explanation-may result from inclusion of patients with acute symptomatic or isolated unprovoked seizures. Other sources of bias include age and ethnic origin of the target population, definitions of epilepsy, retrospective versus prospective ascertainment, sources of cases, and experienced and perceived stigma. Premature mortality is an issue in low-income countries (LICs), where treatment gap, brain infections, and traumatic brain injuries are more common than in high-income countries (HICs). Death rates may reflect untreated continued seizures or inclusion of acute symptomatic seizures. Lack of compliance with antiepileptic drugs has been associated with increased risk for death, increased hospital admissions, motor vehicle accidents, and fractures in poor communities. Epilepsy is a self-remitting clinical condition in up to 50% of cases. Studies in untreated individuals from LICs have shown that the proportion of remissions overlaps that of countries where patients receive treatment. When the identification of patients is based on spontaneous reports (e.g., door-to-door surveys), patients in remission may be less likely to disclose the disease for fear of stigmatization with no concurrent benefits. This might lead to underascertainment of cases when assessing the lifetime prevalence of epilepsy. In LICs, the proportion of people living in poverty is greater than in HICs. Poverty is associated with risk factors for epilepsy, risk for developing epilepsy, and increased mortality. The high incidence and prevalence of epilepsy found in LICs is also observed in low income individuals from HICs. Epileptogenic conditions are associated with an increased mortality. This may partly explain the difference between incidence and lifetime prevalence of epilepsy in LICs. Poverty within LICs and HICs could be a preventable cause of mortality in epilepsy. Wiley Periodicals, Inc.
© 2014 International League Against Epilepsy.

Entities:  

Keywords:  Epidemiology; Epilepsy; Incidence; Mortality; Prevalence; Remission

Mesh:

Year:  2014        PMID: 24966095     DOI: 10.1111/epi.12579

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  19 in total

Review 1.  Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.

Authors:  Kirsten M Fiest; Khara M Sauro; Samuel Wiebe; Scott B Patten; Churl-Su Kwon; Jonathan Dykeman; Tamara Pringsheim; Diane L Lorenzetti; Nathalie Jetté
Journal:  Neurology       Date:  2016-12-16       Impact factor: 9.910

2.  Seizure occurrence, pregnancy outcome among women with active convulsive epilepsy: one year prospective study.

Authors:  Musa Mamman Watila; Omeiza Beida; Shiktra Kwari; Na'awurti Williams Nyandaiti; Yakub Wilberforce Nyandaiti
Journal:  Seizure       Date:  2015-01-14       Impact factor: 3.184

3.  Genetic Knockout of TRPM2 Increases Neuronal Excitability of Hippocampal Neurons by Inhibiting Kv7 Channel in Epilepsy.

Authors:  Yingchao Ying; Lifen Gong; Xiaohan Tao; Junchao Ding; Nannan Chen; Yinping Yao; Jiajing Liu; Chen Chen; Tao Zhu; Peifang Jiang
Journal:  Mol Neurobiol       Date:  2022-09-02       Impact factor: 5.682

4.  Mechanisms Underlying Aquaporin-4 Subcellular Mislocalization in Epilepsy.

Authors:  Jenny I Szu; Devin K Binder
Journal:  Front Cell Neurosci       Date:  2022-06-06       Impact factor: 6.147

5.  Design, Synthesis, and Evaluation of Anticonvulsant Activities of New Triazolopyrimidine Derivatives.

Authors:  Mingxia Song; Wennan Zhao; Yangnv Zhu; Wenli Liu; Xianqing Deng; Yushan Huang
Journal:  Front Chem       Date:  2022-06-23       Impact factor: 5.545

6.  Neurocysticercosis control for primary epilepsy prevention: a systematic review.

Authors:  Zhe Wang; Roxanna M Garcia; Hanalise V Huff; Milagros Niquen-Jimenez; Luis A Marcos; Sandi K Lam
Journal:  Pathog Glob Health       Date:  2021-12-20       Impact factor: 3.735

7.  Prevalence of suicide attempts and their risk factors in school-aged patients with epilepsy: a population-based study.

Authors:  Tomor Harnod; Cheng-Li Lin; Chia-Hung Kao
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-02-02       Impact factor: 4.785

8.  Clinical features of epilepsy at 2 referral hospitals in Northern Iran.

Authors:  Mahdi Rezaeian Yazdi; Morteza Mazloum Farsi Baf; Atena Afsari; Afrouz Alipour; Mostafa Khorashadizadeh; Peyman Khajeh Ghiassi; Seyed Mehran Homam
Journal:  Neurosciences (Riyadh)       Date:  2015-07       Impact factor: 0.906

9.  Healthcare Costs and Absenteeism Among Caregivers of Adults with Partial-Onset Seizures: Analysis of Claims from an Employer Database.

Authors:  Richard A Brook; Krithika Rajagopalan; James E Smeeding
Journal:  Am Health Drug Benefits       Date:  2018-11

10.  Dynamic Expression of CX36 Protein in Kainic Acid Kindling induced Epilepsy.

Authors:  Xue-Mei Wu; Guang-Liang Wang; Xiao-Sheng Hao; Jia-Chun Feng
Journal:  Transl Neurosci       Date:  2017-05-11       Impact factor: 1.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.